Abstract
Leishmaniasis is a global public health problem and one of the six most common parasitic infections in the world, with a prevalence of 12 million patients and an incidence of 2,000,000 new cases per year, of which 1.5 million are cutaneous leishmaniasis (CL). In Brazil, in the period 2001 to 2011 has reported 291,213 new cases of LT. In the treatment of LT, antimony compounds are used as …